Personalized GLP-1 Protocol Compare brand-name medications with our compounded alternatives
SURPASS-4 (PMID 34672967) examined T2D adults with established CVD or high CV risk, comparing tirzepatide against insulin glargine over 52 weeks
Studies show that people sleeping fewer than 7 hours nightly gain weight faster and respond poorly to weight loss medications
Additionally, they reduce oxidative stress and promote nitric oxide synthesis in endothelial cells, improving vascular health
For some people, that may change how a clinician or anesthesia team thinks about timing, symptoms, and risks
A 2020 preclinical toxicity review found no serious toxicity in mice, rats, rabbits, or dogs at tested doses, but longterm human carcinogenicity or organtoxicity data are missing